AAE11 Antibody

Shipped with Ice Packs
In Stock

Description

Anti-EphA1 (AER-011) Antibody

The closest match is AER-011, a well-characterized antibody targeting the extracellular domain of EphA1, a receptor tyrosine kinase involved in cell signaling and cancer progression .

Key Features

  • Target: EphA1 (UniProt P21709)

  • Epitope: Amino acids 457–471 (C-terminus of extracellular domain)

  • Species Reactivity: Human, rat, mouse

  • Applications:

    • Western blot

    • Live-cell imaging

    • Flow cytometry

Validation Data

ApplicationSample TypeResult
Western blotHuman Jurkat cellsClear band at ~110 kDa
ImmunocytochemistryMouse brain membranesSpecific membrane staining

AB011: Anti-CLDNMonoclonal Antibody

AB011 is a humanized IgG1 antibody targeting Claudin18.2 (CLDN18.2), a tight junction protein overexpressed in gastric and pancreatic cancers .

Clinical Trial Highlights (NCT04400383)

  • Phase 1 Results (2023):

    • Monotherapy (30 mg/kg): 46.2% disease control rate in refractory gastric cancer .

    • Combination with CAPOX: 65.2% objective response rate in advanced gastric cancer .

  • Safety: Grade 3 TRAEs included neutropenia (20.8%) and anemia (12.5%) .

AAE-Associated Autoantibodies

In acquired angioedema (AAE), autoantibodies against C1-inhibitor (C1-INH) drive pathogenic effects. While not named "AAE11," these antibodies are critical diagnostic markers :

Diagnostic Performance

MarkerSensitivitySpecificity
IgM-AntiC1INH complex85%96%
IgG-AntiC1INH complex65%88%

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
AAE11 antibody; At1g66120 antibody; F15E12.22Butyrate--CoA ligase AAE11 antibody; peroxisomal antibody; EC 6.2.1.2 antibody; Acyl-activating enzyme 11 antibody; Butyryl-CoA synthetase antibody
Target Names
AAE11
Uniprot No.

Target Background

Function
Butyrate--CoA ligase is an enzyme that exhibits in vitro activity with medium-chain fatty acids. It demonstrates a preference for hexanoate and octanoate.
Database Links

KEGG: ath:AT1G66120

STRING: 3702.AT1G66120.1

UniGene: At.35799

Protein Families
ATP-dependent AMP-binding enzyme family
Subcellular Location
Peroxisome.
Tissue Specificity
Expressed in flowers.

Q&A

Experimental Design for AAE11 Antibody Validation

  • Question: How can I validate the specificity of the AAE11 antibody in my experimental design?

  • Answer: Validation of antibody specificity is crucial for reliable research outcomes. You can use orthogonal methods such as Western blot, immunohistochemistry (IHC), and ELISA to confirm the antibody's target specificity. Additionally, comparing results from multiple antibodies targeting the same antigen can enhance validation .

Data Analysis and Contradiction Resolution

  • Question: What strategies can I employ to resolve contradictory data when using the AAE11 antibody across different experimental conditions?

  • Answer: Contradictory data may arise from variations in experimental conditions or antibody batch differences. To resolve this, ensure consistent experimental conditions, use controls, and validate results with multiple batches of the antibody. Also, consider using computational models to predict potential binding modes and specificity profiles .

Advanced Research Questions: Cross-Reactivity and Specificity

  • Question: How can I assess the cross-reactivity of the AAE11 antibody with closely related antigens, and what implications does this have for my research?

  • Answer: Assessing cross-reactivity involves testing the antibody against a panel of related antigens using techniques like ELISA or Western blot. This is crucial for understanding potential off-target effects and ensuring specificity in complex biological systems. Utilize biophysics-informed models to predict and design antibodies with customized specificity profiles .

Methodological Considerations for Antibody Selection

  • Question: What criteria should I use to select an appropriate antibody for my research, considering factors like citations and user reviews?

  • Answer: When selecting an antibody, consider its citation history in peer-reviewed publications, as this indicates independent validation. Tools like CiteAb can help identify well-cited antibodies. Additionally, user reviews can provide valuable insights into practical performance, though they may be less reliable than peer-reviewed data .

Antibody Characterization and Reproducibility

  • Question: How can I ensure reproducibility in my research when using the AAE11 antibody, given the challenges associated with antibody characterization?

  • Answer: To enhance reproducibility, thoroughly characterize the antibody using multiple validation methods. Ensure consistent experimental conditions and consider using multiple antibodies to confirm findings. Regularly update your methods based on emerging best practices and recommendations from the scientific community .

Advanced Techniques for Antibody Design and Optimization

  • Question: What advanced techniques can I use to design or optimize antibodies like AAE11 for improved specificity and affinity?

  • Answer: Techniques such as phage display and biophysics-informed modeling can be used to design antibodies with customized specificity profiles. These methods allow for the prediction and generation of novel antibody sequences with enhanced affinity and specificity for target antigens .

Interpretation of Results in Complex Biological Systems

  • Question: How can I interpret the results of experiments using the AAE11 antibody in complex biological systems where cross-reactivity might occur?

  • Answer: Interpretation requires careful consideration of potential cross-reactivity and off-target effects. Use controls and validate findings with orthogonal methods. Consider using computational models to predict potential interactions and design follow-up experiments to confirm specificity .

Future Directions in Antibody Research

  • Question: What future directions in antibody research might improve the utility and reliability of antibodies like AAE11?

  • Answer: Future directions include the development of more specific and cross-reactive antibodies using advanced biotechnological methods. Additionally, integrating computational models with experimental approaches will enhance antibody design and validation, leading to more reliable research outcomes .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.